Autres langues Astal Laboratories Limited

Actions

MACINTR

INE307N01014

Produits pharmaceutiques

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:55 10/07/2026			Varia. 5j.	Varia. 1 janv.
82,22 ^INR	+0,09%		-3,47%	-5,33%

30/05	Astal Laboratories Limited publie ses résultats pour le quatrième trimestre clos le 31 mars 2026	CI
14/02	Astal Laboratories Limited publie ses résultats financiers pour le troisième trimestre et les neuf mois clos le 31 décembre 2025	CI

Autres langues

30/05	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026
14/02	Astal Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025
14/01	Astal Laboratories Limited announced that it has received INR 2.768732512 billion in funding from a group of investors
29/12	Astal Laboratories signed letter of intent with Immuna Therapeutics GmbH
25/11	Astal Laboratories Limited Receives REACH Compliance Certificate
25/11	Astal Laboratories Limited Secures Letter of Intent for 60 Tonnes of Piroctone Olamine from Swiss Distributor
14/11	Astal Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025
10/10/25	Astal Laboratories to buy 100% of Sriven Pharmachem
10/10/25	Astal Laboratories Limited agreed to acquire Sriven Pharmachem Pvt Ltd for INR 2.6 billion.
12/08/25	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025
19/05/25	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025
19/05/25	Astal Laboratories Limited Constitutes the Csr Committee of Board, Effective May 19, 2025
28/01/25	Astal Laboratories Limited Approves Change in Corporate Office Address
27/01/25	Astal Laboratories Limited Announces Change in the Address of Keeping & Maintaining Books of Accounts place
23/12/24	Astal Laboratories Limited Announces Change in Registered Office Address
23/12/24	Astal Laboratories Limited Appoints Dr. Julius Paul Reinhard Paschke as Independent Director (Non-Executive)
27/11/24	Astal Laboratories Limited announced that it has received INR 37.2993 million in funding
15/10/24	Astal Laboratories Limited Announces Acquisition of Pharmaceutical Intermediates Manufacturing Plant
06/08/24	Astal Laboratories Limited Approves Appointment of Birendrakumar Sahoo as Non Executive Independent Director
27/07/24	Astal Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024
06/07/24	Astal Laboratories Limited announced that it expects to receive INR 57.1993 million in funding from Aceso Research Labs LLP and other investors
25/05/24	Astal Laboratories Limited Appoints BIRENDRAKUMAR SAHOO as Additional Non-Executive Independent Director
24/05/24	Astal Laboratories Limited Announces Change in Corporate Office Address
24/05/24	Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
24/05/24	Astal Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024